Back to News
Health & Wellness
Sep 17, 20260 views2 min read

FDA Approves Four Updated COVID-19 Vaccines for the 2026-2027 Respiratory Season

The FDA approved four updated COVID-19 vaccines for the 2026-2027 respiratory season in September 2026. Four independent medical groups also issued updated guidance recommending flu vaccinations for all individuals aged 6 months and older. Health officials say the updated vaccines are designed to better match currently circulating virus strains.

FDA Approves Four Updated COVID-19 Vaccines for the 2026-2027 Respiratory Season
Source:Healthline

The FDA approved four updated COVID-19 vaccines for the 2026-2027 respiratory season in September 2026, as health officials prepare for the fall and winter virus season.

The approvals cover updated formulations designed to better match currently circulating strains of the virus. The FDA said the updated vaccines are expected to provide stronger protection against severe illness, hospitalization, and death compared to older formulations.

Separately, four independent medical groups issued updated guidance for the 2026-2027 respiratory season, recommending flu vaccinations for all individuals aged 6 months and older. The groups said annual flu vaccination remains one of the most effective tools for reducing hospitalizations and deaths from influenza each year.

Health officials are encouraging Americans to get both their updated COVID-19 vaccine and their annual flu shot this fall. The two vaccines can be administered at the same visit.

The respiratory virus season typically runs from October through March, with peak activity in December and January. Last year's season saw elevated hospitalizations among adults over 65 and young children under 5.

Pharmacies, doctor's offices, and community health centers are expected to begin offering the updated COVID-19 vaccines in the coming weeks. Officials said supply is expected to be adequate to meet demand.

The CDC recommends that most adults receive the updated COVID-19 vaccine annually, similar to the approach used for flu shots. People with weakened immune systems may need additional doses.

Related Articles

Reading for Pleasure Linked to 33 Percent Lower Risk of Alzheimer's Disease, New Research Shows
Read More
Health & WellnessThe Telegraph

Reading for Pleasure Linked to 33 Percent Lower Risk of Alzheimer's Disease, New Research Shows

New research published in September 2026 found that people who read for pleasure throughout their lives have a significantly lower risk of developing Alzheimer's disease and cognitive decline. A study tracking nearly 2,000 participants found that those with the highest levels of lifetime cognitive enrichment, including reading and writing, had a 38 percent lower risk of Alzheimer's and experienced its onset an average of six years later.

01
Even Low Levels of Light During Sleep Linked to Higher Risk of Heart Failure and Atrial Fibrillation
Read More
Health & WellnessHealthline

Even Low Levels of Light During Sleep Linked to Higher Risk of Heart Failure and Atrial Fibrillation

New research published in September 2026 found that exposure to even low levels of light, as little as 3 lux, during sleep is associated with increased risks of heart failure and atrial fibrillation. Researchers say the findings suggest that sleeping in a dark room may be an important and overlooked factor in cardiovascular health.

01
Study Finds Human Brain Undergoes Major Genomic Shift Between Ages 50 and 75
Read More
Health & WellnessScience Daily

Study Finds Human Brain Undergoes Major Genomic Shift Between Ages 50 and 75

A new study found that the human brain undergoes sweeping genomic organizational changes between the ages of 50 and 75. Researchers say the findings help explain why the risk of neurodegenerative diseases like Alzheimer's rises sharply during midlife and beyond.

08